PMPMEase-IN L-28
| Code | Size | Price |
|---|
| TAR-T24651-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T24651-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
| TAR-T24651-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
PMPMEase-IN L-28 is a novel inhibitor of prenylated methylated protein methylesterase.
CAS:
1190196-77-0
Formula:
C17H29FO2S2
Molecular Weight:
348.54
Purity:
0.98
SMILES:
CC(C)=CCCC(C)=CCCC(C)=CCSCCS(F)(=O)=O
References
1. Leisser A, Nejabat M, Hartenbach M, Agha Mohammadi Sareshgi R, Shariat S, Kramer G, Krainer M, Hacker M, Haug AR. Analysis of hematological parameters as prognostic markers for toxicity and survival of (223)Radium treatment. Oncotarget. 2018 Mar 5;9(22):16197-16204. doi: 10.18632/oncotarget.24610. eCollection 2018 Mar 23. PubMed PMID: 29662636; PubMed Central PMCID: PMC5882327.
2. Philippe C, Gr?goir AF, Thor? ESJ, Brendonck L, De Boeck G, Pinceel T. Acute sensitivity of the killifish Nothobranchius furzeri to a combination of temperature and reference toxicants (cadmium, chlorpyrifos and 3,4-dichloroaniline). Environ Sci Pollut Res Int. 2018 Apr;25(10):10029-10038. doi: 10.1007/s11356-018-1278-x. Epub 2018 Jan 29. PubMed PMID: 29380199.
3. DasGupta RK, Levine L, Wiczer T, Cataland S. Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia. J Oncol Pharm Pract. 2018 Jan 1:1078155217748470. doi: 10.1177/1078155217748470. [Epub ahead of print] PubMed PMID: 29298625.
4. Kali?czuk ?, Zieli?ski K, Pr?gowski J, Przy?uski J, Karcz M, Bekta P, Ciszewski M, Dzieli?ska Z, Witkowski A, Demkow M. Higher admission glycaemia independently of diagnosed or unrecognised diabetes mellitus is a risk factor for failed myocardial tissue reperfusion and higher mortality after primary angioplasty. Kardiol Pol. 2018;76(3):594-601. doi: 10.5603/KP.a2017.0258. Epub 2018 Jan 3. PubMed PMID: 29297192.